drugset / Trial / NCT05187104

Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells

NCT05187104

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Treatment of age-related macular degeneration using retinal stem and progenitor cells

Timeline

Start
2022-03-01
Primary completion
2023-12-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject rHIV7-shI-TAR-CCR5RZ-transduced Hematopoietic Stem/Progenitor Cells Unknown Other